Multiple Tumours

Gene: KIT

Amber List (moderate evidence)

KIT (KIT proto-oncogene receptor tyrosine kinase)
EnsemblGeneIds (GRCh38): ENSG00000157404
EnsemblGeneIds (GRCh37): ENSG00000157404
OMIM: 164920, Gene2Phenotype
KIT is in 16 panels

1 review

Ellen McDonagh (Genomics England Curator)

Information from TruSight panel: Pathogenic Mutations are Activating.
Created: 5 Feb 2016, 11:46 a.m.

Mode of pathogenicity
Other - please provide details in the comments

Details

Mode of Inheritance
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
Sources
  • Expert Review Amber
  • UKGTN
  • TruSight Cancer Panel (Illumina)
Phenotypes
  • Gastro-Intestinal Stromal Tumor
OMIM
164920
Clinvar variants
Variants in KIT
Penetrance
Complete
Publications
Mode of Pathogenicity
Loss-of-function variants (as defined in pop up message) DO NOT cause this phenotype - please provide details in the comments
Panels with this gene

History Filter Activity

18 Apr 2017, Gel status: 2

Set publications

Ellen McDonagh (Genomics England Curator)

Publications for KIT were set to 9697690;28314314

18 Apr 2017, Gel status: 2

Gene classified by Genomics England curator

Ellen McDonagh (Genomics England Curator)

This gene has been classified as Amber List (Moderate Evidence).

18 Apr 2017, Gel status: 1

Set publications

Ellen McDonagh (Genomics England Curator)

Publications for KIT were set to 9697690

18 Apr 2017, Gel status: 1

Set mode of pathogenicity

Ellen McDonagh (Genomics England Curator)

Mode of pathogenicity for KIT was changed to Loss-of-function variants (as defined in pop up message) DO NOT cause this phenotype - please provide details in the comments

18 Apr 2017, Gel status: 1

Upload gene information

Ellen McDonagh (Genomics England Curator)

KIT was added to Multiple Tumourspanel. Sources: UKGTN

5 Feb 2016, Gel status: 0

Created

Ellen McDonagh (Genomics England Curator)

KIT was created by ellenmcdonagh

5 Feb 2016, Gel status: 0

Added New Source

Ellen McDonagh (Genomics England Curator)

KIT was added to Multiple Tumourspanel. Sources: TruSight Cancer Panel (Illumina)